NCT02546661 2025-12-29
BISCAY
AstraZeneca
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT06916494 2025-04-10
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
First Affiliated Hospital of Chongqing Medical University
Phase 1 Recruiting
NCT05860543 2024-09-25
Clinical Performance Evaluation of the C2i Test
University of Texas Southwestern Medical Center
Withdrawn
NCT05979740 2023-08-31
RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC
RenJi Hospital
Phase 2 Unknown
NCT04813107 2022-02-22
ANTICIPATE
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 1/2 Unknown
NCT02716896 2019-11-25
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase NA Terminated
NCT04101812 2019-09-26
Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT02648100 2017-06-20
DIATRIBBE
Assistance Publique - Hôpitaux de Paris
Unknown